IIPS, 2017. National family health survey (NFHS-4). International Institute for Population Sciences Deonar,, http://rchiips.org/NFHS/NFHS-4Reports/India.pdf.
Who., 2011. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. World Health Organization., https://apps.who.int/iris/handle/10665/85839.
Shokrgozar, N. and H.A. Golafshan, 2019. Molecular perspective of iron uptake, related diseases, and treatments. Blood Res., 54: 10-16.
Patel, J., K. Patel, J. Patel, A. Sharma and S.K. Date, 2015. Comparison of intravenous iron sucrose and ferric carboxymaltose therapy in iron deficiency anemia during pregnancy and postpartum period. J. Pharm. Sci. Bioscient. Res., 5: 239-243.
Froessler, B., J. Collingwood, N.A. Hodyl and G. Dekker, 2014. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth, Vol. 14. 10.1186/1471-2393-14-115.
Pels, A. and W. Ganzevoort, 2015. Safety and efficacy of ferric carboxymaltose in anemic pregnant women: A retrospective case control study. Obstet. Gynecol. Int., Vol. 2015. 10.1155/2015/728952.
Rodriguez, R.A., M.G. Montero, J.P.L. Aporta, C.G. Luque and A.C. Mayor et al., 2016. Retrospective case reports of anemic pregnant women receiving intravenous ferric carboxymaltose: Experience from a tertiary hospital in Spain. Obstet. Gynecol. Int., Vol. 2016. 10.1155/2016/5060252.
Mohiuddin, M.F., S.M. Sameer, S. Mohiuddin, K. Saravanan and M. Sangeereni, 2019. A study on safety and efficacy of ferric carboxymaltose in anaemic patients during pregnancy. Pharma Innov. J., 8: 1265-1270.
Christoph, P., C. Schuller, H. Studer, O. Irion, B.M.D. Tejada and D. Surbek, 2012. Intravenous iron treatment in pregnancy: Comparison of high-dose ferric carboxymaltose vs. iron sucrose. J. Perinatal Med., 40: 469-474.